Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

UofFl has Chang. They have no use for Radient/NuVax.

You apparently don't realize that Radient/NuVax was paying UofFl, not the other way around.

Radient/NuVax has no resources that the University of Florida wants or can use.

Again, I suggest you read the SEC Filings. Here is a timeline of what happened:

early December 2010: NuVax hires Bhatia and Chang.

late December 2010: NuVax abandons CIT.

January 2011: NuVax pays the University of Florida to license Chang's newer technology. They pay them with NuVax shares (and maybe some cash).

July 2011: Radient goes broke. They cannot pay Bhatia or Chang.
Chang quits, Bhatia quits. The University of Florida terminates the agreements. NuVax has nothing except CIT, which they have already declared is worthless.

So the University of Florida is left holding some NuVax shares. That and a dollar won't buy a cup of coffee.